Mary Patterson
Pediatric Endocrinology · San Diego, CANPI 1912112020
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 175 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 17.4% — the pattern of someone who eats at a lot of different presentations.
Across 175 payments — averaging $24.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$761
- AbbVie$425
- Ferring Pharmaceuticals Inc.$376
- Tandem Diabetes Care, Inc.$331
- Insulet Corporation$267
- BETA Bionics, Inc.$248
- plus $2K from 19 others
Across 1 payment — averaging $11,491 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Biomarin Pharmaceutical Inc.$11K
What the payments were for
- Food & beverage$4,362100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 35 | $761 |
| AbbVie | 23 | $425 |
| Ferring Pharmaceuticals Inc. | 15 | $376 |
| Tandem Diabetes Care, Inc. | 12 | $331 |
| Insulet Corporation | 11 | $267 |
| BETA Bionics, Inc. | 10 | $248 |
| Dexcom, Inc. | 11 | $239 |
| Azurity Pharmaceuticals, Inc. | 11 | $232 |
| Ipsen Biopharmaceuticals, Inc | 7 | $190 |
| Tolmar, Inc. | 3 | $179 |
| Companion Medical, Inc. | 4 | $157 |
| Eton Pharmaceuticals, Inc. | 2 | $144 |
| Sanofi-aventis U.S. LLC | 1 | $141 |
| Ascendis Pharma Endocrinology Inc | 4 | $115 |
| Arbor Pharmaceuticals, Inc. | 6 | $102 |
| Pfizer | 4 | $81 |
| Kyowa Kirin, Inc. | 3 | $76 |
| AstraZeneca | 3 | $69 |
| Neurocrine Biosciences, Inc. | 2 | $65 |
| Lilly USA, LLC | 3 | $52 |
| Medtronic | 1 | $32 |
| BD | 1 | $27 |
| Sandoz | 1 | $22 |
| IBSA Pharma Inc. | 1 | $17 |
| Soleno Therapeutics, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,362 in reported general payments places this provider in the 70th percentile of 168 pediatric endocrinology providers in California.
Other pediatric endocrinology in San Diego
- Karen KleinSan Diego$195K
- Marcela Vargas TrujilloSan Diego$57K
- Ron NewfieldSan Diego$27K
- Michael GottschalkSan Diego$17K
- Susan PhillipsSan Diego$12K
- Maja MarinkovicSan Diego$5K
- Jane KimSan Diego$3K
- Gnanagurdasan PrakasamSacramento$805K
- Swati ElchuriVentura$210K
- Francine KaufmanLos Angeles$184K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.